ATALANTA

Atalanta was founded by world-leading experts in RNA interference to pioneer new treatment options for intractable neurodegenerative diseases... We take our name from the mythological Greek heroine Atalanta, a fierce huntress and, in some accounts, the only woman to sail with the Argonauts in their quest for the Golden Fleece. The protein Argonaute 2 plays an essential role in RNA interference - and like the Argonauts, we are visionary and courageous in our exploration of new frontiers... Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders' groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source.

Primary location: Boston United States